Ticker
ACRVCompany Name
ACRIVON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
---|---|---|---|---|
6/30/2025 | $ 42.1M | $ 3.26M | $ 2.37M | $ 41.21M |
3/31/2025 | $ 39.35M | $ 3.51M | $ -92.89K | $ 35.75M |
12/31/2024 | $ 40.02M | $ 3.65M | $ 42.63M | $ 79.01M |
9/30/2024 | $ 43.61M | $ 4.01M | $ 207.31M | $ 246.91M |
6/30/2024 | $ 46.43M | $ 4.22M | $ 182.34M | $ 224.55M |
3/31/2024 | $ 25.02M | $ 4.45M | $ 237.55M | $ 258.13M |
12/31/2023 | $ 36.43M | $ 4.64M | $ 130.07M | $ 161.85M |
9/30/2023 | $ 30.27M | $ 4.42M | $ 76.02M | $ 101.87M |
6/30/2023 | $ 38.48M | $ 4.6M | $ 239.6M | $ 273.48M |
3/31/2023 | $ 27.88M | $ 4.79M | $ 274.44M | $ 297.54M |
Market Cap + Debt - CashnEq
(=) EV
EV for ACRIVON THERAPEUTICS INC is calculated as follows: Market Cap [ $ 0 ] + Debt [ $ 5.63M ] - CashnEq [ $ 99.99M ]
(=) EV [ $ 0 ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.32K |
---|---|
min | $ -1.69B |
max | $ 6.88B |
average | $ 1.25B |
median | $ 439.6M |
std | $ 1.67B |